Simultaneously, we investigated the circulating levels of other proinflammatory or immunomodulating cytokines previously suggested as potential biomarkers in NSCLC, albeit normal cohort comparisons in those studies were not always available, which includes IL-6 [24], IL-8 [25], IL-17A [26], and IL-33 [27]. This evidence concerns the gene IL33 and non-small cell lung carcinoma.